Medline Inc. Class A Common Stock (MDLN)vsPulse Biosciences Inc (PLSE)
MDLN
Medline Inc. Class A Common Stock
$42.03
-1.06%
HEALTHCARE · Cap: $34.68B
PLSE
Pulse Biosciences Inc
$22.02
+3.43%
HEALTHCARE · Cap: $958.23M
Smart Verdict
WallStSmart Research — data-driven comparison
Medline Inc. Class A Common Stock generates 33060364% more annual revenue ($28.43B vs $86,000). MDLN leads profitability with a 4.1% profit margin vs 0.0%. MDLN earns a higher WallStSmart Score of 52/100 (C-).
MDLN
Buy52
out of 100
Grade: C-
PLSE
Avoid16
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+32.7%
Fair Value
$66.92
Current Price
$42.03
$24.89 discount
Intrinsic value data unavailable for PLSE.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Conservative balance sheet, low leverage
Areas to Watch
Moderate valuation
ROE of 6.5% — below average capital efficiency
4.1% margin — thin
Negative free cash flow — burning cash
Trading at 16.1x book value
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
Comparative Analysis Report
WallStSmart ResearchBull Case : MDLN
Revenue growth of 14.8% demonstrates continued momentum.
Bull Case : PLSE
The strongest argument for PLSE centers on Debt/Equity.
Bear Case : MDLN
The primary concerns for MDLN are P/E Ratio, Return on Equity, Profit Margin. Thin 4.1% margins leave little buffer for downturns.
Bear Case : PLSE
The primary concerns for PLSE are Price/Book, Revenue Growth, EPS Growth.
Key Dynamics to Monitor
MDLN is growing revenue faster at 14.8% — sustainability is the question.
PLSE generates stronger free cash flow (-15M), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MDLN scores higher overall (52/100 vs 16/100) and 14.8% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Medline Inc. Class A Common Stock
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.
Visit Website →Pulse Biosciences Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Pulse Biosciences, Inc. is a bioelectrical medicine startup. The company is headquartered in Hayward, California.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?